Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ASH 2022 | Unmet needs in GvHD & the promise of regenerative medicine

Shernan Holtan, MD, University of Minnesota, Minneapolis, MN, discusses unmet needs in graft-versus-host disease (GvHD) and challenges to address when treating patients. Dr Holtan highlights the importance of exploring GvHD treatment options that are not overly immunosuppressive, highlighting the promise of regenerative medicine. This interview took place at the 64th ASH Annual Meeting and Exposition congress in New Orleans, LA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Incyte: Research Funding; Vitrac Therapeutics: Research Funding; CSL Behring: Other: Clinical trial adjudication.